Anaut
Latest round
- Series B
Last raised
- May 2026
Total raised
- Undisclosed
Investors
- 7
About Anaut
Founded in 2020 and based in Tokyo Japan, Anaut Inc.a Anaut develops advanced surgical assistance technologies, focusing on enhancing surgical outcomes through its EUREKA AI system, which provides real-time physiological data analysis for surgical procedures. Anaut specializes in surgical assistance technologies. The founder's history information is not available. Anaut specializes in advanced surgical assistance technologies, primarily through its flagship product, the EUREKA AI system. This state-of-the-art platform analyzes complex internal physiological data in real-time, enhancing the surgical process by providing surgeons with precise, individualized visualizations of a patient's unique anatomical structures during operations. EUREKA leverages deep learning from extensive surgical video datasets, continually improving its accuracy and expanding its application to various surgical fields, including thoracic, abdominal, and pelvic surgeries. The company aims to deliver unprecedented safety and reliability to all patients requiring surgical intervention, positioning itself as a crucial partner for surgeons in both Japan and international markets. The end users of these technologies include hospitals, surgical centers, and medical professionals who seek to enhance surgical outcomes and patient safety. Anaut generates revenue through a straightforward transaction structure involving B2B sales to healthcare institutions and practitioners. The company offers its surgical assistance systems under both medical and educational versions, catering to different segments within the healthcare market. Clients engage with Anaut via direct partnerships, where they acquire licenses or subscriptions for the EUREKA AI system to integrate it into their surgical protocols. The pricing structure reflects the high value of advanced technological solutions in surgery, with potential tiered pricing based on the extent of features and support services offered. The educational version may also create additional revenue streams, targeting medical schools and training programs that require advanced surgical education tools. Anaut plans to design and launch new products aimed at enhancing their EUREKA AI system's capabilities, although specific release dates are not available. The company targets expansion into international markets, particularly in regions with growing demand for advanced surgical technologies. The company plans to use May 2026 funds to accelerate overseas expansion, advance R&D including new business launches, and strengthen product distribution and market reach.
Who invested in Anaut
7 investors across 1 round
See all investors in Anaut
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
May 13, 2026
Amount
Undisclosed
Investors
Questions about Anaut
Who invested in Anaut?
Anaut has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Anaut raised?
Anaut has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Anaut last raise money?
Anaut's most recent round on record is a Series B, in May 2026.
What does Anaut do?
Founded in 2020 and based in Tokyo Japan, Anaut Inc.
Where is Anaut headquartered?
Anaut is headquartered in Japan.
Which VCs invest in companies like Anaut?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back healthcare it companies at Anaut's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series B
Raising like Anaut? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.